Caxton Associates (New York)’s Andeavor ANDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-85,000
Closed -$6.76M 290
2016
Q3
$6.76M Buy
+85,000
New +$6.55M 0.23% 73
2016
Q2
Sell
-15,000
Closed -$1.29M 228
2016
Q1
$1.29M Buy
+15,000
New +$1.29M 0.09% 97
2015
Q1
Sell
-35,500
Closed -$2.64M 214
2014
Q4
$2.64M Buy
+35,500
New +$2.5M 0.2% 81
2014
Q1
Sell
-37,468
Closed -$2.19M 289
2013
Q4
$2.19M Sell
37,468
-52,532
-58% -$2.73M 0.07% 116
2013
Q3
$3.96M Buy
+90,000
New +$4.48M 0.21% 84

Other funds holding ANDV

Caxton Associates (New York)'s ANDV Position: Q4 2016 in Review

Caxton Associates (New York) sold out of Andeavor (ANDV) in Q4 2016, closing a stake of 85,000 shares — an estimated $6.76M sold.

Caxton Associates (New York) first reported a position in ANDV in Q3 2013 and held it in 5 quarters. The position peaked at $6.76M in Q3 2016. 519 funds tracked by Wall St. Rank hold ANDV as of Q4 2016.

  • Caxton Associates (New York) reported no remaining Andeavor position as of Q4 2016 after selling out during the quarter.
  • Caxton Associates (New York) sold 85,000 Andeavor shares in Q4 2016, an estimated $6.76M.
  • Caxton Associates (New York) first reported a position in Andeavor in Q3 2013 and held it in 5 quarters.
  • Caxton Associates (New York)'s Andeavor position peaked at $6.76M in Q3 2016.
  • 519 funds tracked by Wall St. Rank held Andeavor as of Q4 2016.

Based on Caxton Associates (New York)'s 13F filing for Q4 2016, filed 14 Feb 2017.